NEWS
Nviro Cleantech considers making offer for Southbank
N
viro Cleantech plc has made a proposal to Southbank UK plc, the parent company of Hayward Tyler Group Ltd, which may lead to an offer being made for the entire issued and to be issued share capital of Southbank. The proposal remains subject to Nviro Cleantech’s completion of satisfactory due diligence into Southbank and the unanimous recommendation of the Southbank board. Hayward Tyler Group is one of the oldest engineering companies in the UK designing and manufacturing pumps and motors for the oil and gas and power generation industries. Nviro Cleantech specialises in commercialising clean technologies, building them from the innovation stage to industrial scale. For further information, visit www.southbankplc.com, www.nvirocleantech.com and www.haywardtyler.com
¥0.6 billion and order backlog of ¥57.1 billion at the same half year point a year earlier. For further information, visit www.torishima.co.jp
Grundfos expands in Egypt
G
rundfos has set up a new sales company in Cairo, Egypt. Grundfos Egypt will focus on project solutions within building services, agriculture, infrastructure and OEM water treatment. The new Grundfos premises will include operating demonstration units and facilities for customer training. ”It is our mission to be the market leader in our core markets with pump solutions and value added services. Our partners and stake holders will relieve some of the region’s most urgent challenges within water, treatment, and energy efficient solutions,” said Mike Otten, general manager of the new company. The Danish pump company has been represented in Egypt since 2002 by its sales company in Dubai, United Arab Emirates.
For further information, visit www.grundfos.com
Torishima adds service facility in UAE
J
apan’s Torishima Pump Mfg Co Ltd has opened a new engineering, service and pump plant solutions company in Dubai, United Arab Emirates. Torishima Service Solutions LLC, which is located in Dubai’s TechnoPark, will provide maintenance for more than 10 000 of the company’s pumps that are installed in the Middle East. Parent company Torishima Pump Mfg has invested ¥1 billion in the new venture, which will employ 50 people. Torishima Service Solutions is expected to generate annual revenues of ¥50 billion. In the six months to 30 September 2009, Torishima Pump Mfg secured orders worth ¥22.2 billion, sales of ¥20.9 billion, operating profit of ¥1.0 billion and net profit of ¥1.2 billion. Order backlog at the end of the period was ¥51.7 billion. This compares with orders of ¥27.8 billion, sales of ¥19.8 billion, operating profit of ¥0.7 billion, net profit of 16
Pump Industry Analyst
Energy Recovery opens new corporate HQ
E
nergy Recovery Inc (ERI) has relocated its corporate headquarters and manufacturing operations to a nearby facility in San Leandro, California that will include ceramics research and production capabilities. The new headquarters combine the company’s business and manufacturing operations into a single 165 000 sq ft facility allowing for an increase in production capacity for ERI’s PX pressure exchanger. “Our new headquarters provides ERI with a distinctive competitive edge, as it enables us to integrate our supply chain and expand our product offerings through extensive, unmatched research and development capabilities. We look forward to years of continued success in the new location as we further strengthen our position as the industry’s leading provider of energy recovery devices,” said GG Pique, Energy Recovery president and CEO.
For further information, visit www.energyrecovery.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail:
[email protected] Production Support Manager: Lin Lucas E-mail:
[email protected] Publisher: Laurence Zipson E-mail:
[email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1112 for all European countries & Iran US$1247 for all countries except Europe and Japan ¥147 800 for Japan (Prices valid until 31 December 2009) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ Email:
[email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
December 2009